fluorouracil and lutetium

fluorouracil has been researched along with lutetium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barber, TW; Hicks, RJ; Hofman, MS; Thomson, BN	1
Gillani, SJ; Naqvi, SA; Rasheed, R; Rasheed, S; Rizvi, FA; Sajid, M; Tariq, S	1

Other Studies

2 other study(ies) available for fluorouracil and lutetium

Article	Year
The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2012, Volume: 38, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Duodenal Neoplasms; Fluorouracil; Humans; Lutetium; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Remission Induction; Research Design; Tomography, X-Ray Computed; Treatment Outcome	2012
(177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy. Journal of labelled compounds & radiopharmaceuticals, 2016, Volume: 59, Issue:10 Topics: Animals; Drug Stability; Fluorouracil; Half-Life; Isotope Labeling; Lutetium; Male; Quality Control; Rabbits; Radiochemistry; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution	2016

Article

Year

The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2012, Volume: 38, Issue:1

Topics: Aged; Antimetabolites, Antineoplastic; Duodenal Neoplasms; Fluorouracil; Humans; Lutetium; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Remission Induction; Research Design; Tomography, X-Ray Computed; Treatment Outcome

2012

(177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy.

Journal of labelled compounds & radiopharmaceuticals, 2016, Volume: 59, Issue:10

Topics: Animals; Drug Stability; Fluorouracil; Half-Life; Isotope Labeling; Lutetium; Male; Quality Control; Rabbits; Radiochemistry; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution

2016